No connection

Search Results

FN

BEARISH
$720.19 Live
Fabrinet · NYSE
Target $680.0 (-5.6%)
$193.54 52W Range $734.79

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 27, 2026
Market cap
$25.8B
P/E
68.98
ROE
18.7%
Profit margin
9.7%
Debt/Equity
0.0
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Fabrinet exhibits a critical disconnect between its market price ($720.19) and its fundamental value, with a weak Piotroski F-Score of 3/9 indicating deteriorating financial health trends. While the company boasts impressive revenue growth (35.9%) and a pristine balance sheet with zero debt, it is trading at a massive premium to its Intrinsic Value ($307.98) and Graham Number ($119.69). The combination of a high P/E ratio (68.98), bearish insider selling, and a failing technical trend suggests the stock is currently in a valuation bubble.

Key Strengths

Zero debt-to-equity ratio indicating an exceptionally clean balance sheet
Strong top-line growth with 35.9% YoY revenue increase
Consistent earnings track record with beats in the majority of the last 25 quarters
High liquidity with a current ratio of 2.68
Strong historical price performance (+681.9% over 5 years)

Key Risks

Extreme overvaluation with a P/E of 68.98 and P/B of 11.81
Weak Piotroski F-Score (3/9) suggesting declining operational efficiency
Bearish insider sentiment with $14.27M in sales and zero buys
Current price is significantly above the analyst target price of $680
Technical trend is heavily bearish (10/100)
AI Fair Value Estimate
Based on comprehensive analysis
$350.0
-51.4% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
44
Moderate
Value
15
Future
85
Past
90
Health
30
Dividend
0
AI Verdict
Overvalued Growth Play
Key drivers: Extreme valuation premium, Strong revenue growth, Poor deterministic health score (Piotroski), Insider liquidation
Confidence
90%
Value
15/100

Ref P/E 68.98, Graham Number $119.69

Positives
No standout positives identified.
Watchpoints
  • P/E of 68.98 is excessive
  • Price is 6x the Graham Number
  • Price/Book of 11.81 is very high
Future
85/100

Ref Growth rates

Positives
  • 35.9% Revenue Growth
  • 30.7% Earnings Growth
Watchpoints
  • Growth must be perfect to justify current multiple
Past
90/100

Ref Historical trends

Positives
  • Massive 5Y return of 681.9%
  • Consistent EPS beat history
Watchpoints
No urgent risks highlighted.
Health
30/100

Ref Piotroski F-Score 3/9

Positives
  • Zero Debt
  • Strong Current Ratio
Watchpoints
  • Piotroski F-Score of 3/9 indicates weak financial health trends
Dividend
0/100

Ref Yield 0%

Positives
No standout positives identified.
Watchpoints
  • No dividend payments

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$720.19
Analyst Target
$680.0
Upside/Downside
-5.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for FN and closest competitors.

Updated 2026-04-24
FN
Fabrinet
Primary
5Y
+681.9%
3Y
+661.5%
1Y
+261.9%
6M
+71.1%
1M
+17.7%
1W
+4.4%
TSE
Tower Semiconductor Ltd.
Peer
5Y
+670.1%
3Y
+401.1%
1Y
+536.3%
6M
+197.6%
1M
+37.2%
1W
+7.2%
GFS
GLOBALFOUNDRIES Inc.
Peer
5Y
+5.0%
3Y
-28.1%
1Y
+34.6%
6M
+37.8%
1M
+4.4%
1W
+11.3%
BR
Broadridge Financial Solutions, Inc.
Peer
5Y
+49.7%
3Y
+45.2%
1Y
-10.9%
6M
-17.5%
1M
-9.1%
1W
-5.1%
ZM
Zoom Communications, Inc.
Peer
5Y
-75.4%
3Y
+8.9%
1Y
+9.0%
6M
-2.6%
1M
+10.6%
1W
+5.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
68.98
Forward P/E
43.13
PEG Ratio
N/A
P/B Ratio
11.81
P/S Ratio
6.63
EV/Revenue
6.38
EV/EBITDA
57.09
Market Cap
$25.8B

Profitability

Profit margins and return metrics

Profit Margin 9.69%
Operating Margin 10.1%
Gross Margin 12.01%
ROE 18.72%
ROA 8.12%

Growth

Revenue and earnings growth rates

Revenue Growth +35.9%
Earnings Growth +30.7%
Q/Q Revenue Growth +35.9%
Q/Q Earnings Growth +30.0%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.0
Low debt
Current Ratio
2.68
Strong
Quick Ratio
1.7
Excellent
Cash/Share
$26.82

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$1.1B
Gross Margin
12.2%
Op. Margin
10.1%
Net Margin
9.9%
Total Assets
$3.3B
Liabilities
$1.1B
Equity
$2.2B
Debt/Equity
0.50x
Operating CF
$0.0B
CapEx
$-0.1B
Free Cash Flow
$-0.0B
FCF Yield
-12%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-04
$N/A
2026-02-02
$3.36
+3.4% surprise
2025-11-03
$2.92
+3.6% surprise
2025-08-18
$2.42
-5.1% surprise

Technology Sector Comparison

Comparing FN against 555 companies in the Technology sector (45 bullish, 190 neutral, 320 bearish)
P/E Ratio
68.98
This Stock
vs
82.84
Sector Avg
-16.7% (Discount)
Return on Equity (ROE)
18.72%
This Stock
vs
-34.19%
Sector Avg
-154.8% (Below Avg)
Profit Margin
9.69%
This Stock
vs
-12.18%
Sector Avg
-179.5% (Weaker)
Debt to Equity
0.0
This Stock
vs
0.73
Sector Avg
-99.7% (Less Debt)
Revenue Growth
35.9%
This Stock
vs
4463.53%
Sector Avg
-99.2% (Slower)
Current Ratio
2.68
This Stock
vs
3.62
Sector Avg
-26.0% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

KELLY THOMAS F.
Director
Gift
2026-02-26
150 shares
KELLY THOMAS F.
Director
Sell
2026-02-25
1,850 shares · $1,154,131
KELLY THOMAS F.
Director
Stock Award
2025-12-11
417 shares
DOWLING CAROLINE
Director
Stock Award
2025-12-11
417 shares
LEVINSON FRANK H
Director
Stock Award
2025-12-11
417 shares
ALEXANDER FORBES I J
Director
Stock Award
2025-12-11
417 shares
BAHRAMI HOMA
Director
Stock Award
2025-12-11
417 shares
KELLY THOMAS F.
Director
Gift
2025-12-05
25 shares
KNIGHT DARLENE
Director
Sell
2025-12-05
500 shares · $241,056
KELLY THOMAS F.
Director
Sell
2025-12-04
2,200 shares · $1,021,112
KNIGHT DARLENE
Director
Sell
2025-12-04
500 shares · $236,000
OLSON ROLLANCE E.
Director
Gift
2025-12-03
70 shares
BAHRAMI HOMA
Director
Sell
2025-12-01
3,500 shares · $1,588,114
GRADY SEAMUS
Chief Executive Officer
Sell
2025-11-26
22,451 shares · $10,034,497
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

10-Q
10-Q
2026-02-03

FN submitted its quarterly 10-Q filing on February 3, 2026. While specific financial highlights were not provided in the excerpt, the filing includes a dedicated section on risk factors under Item 1A.

8-K
8-K
2026-02-02

FN likely filed this 8-K on February 2, 2026, to announce its fourth quarter and full-year financial results.

8-K
8-K
2025-12-12
10-Q
10-Q
2025-11-04

FN filed its 10-Q on November 4, 2025. While specific financial highlights were not provided in the excerpt, the filing includes a section detailing risk factors under Item 1A.

8-K
8-K
2025-11-03

FN filed an 8-K on November 3, 2025, likely to announce its third-quarter financial results.

DEF 14A
DEF 14A
2025-10-23

FN filed a Definitive Proxy Statement on October 23, 2025, providing shareholders with necessary information to vote on matters at the company's upcoming meeting.

8-K
8-K
2025-10-17

FN filed an 8-K on October 17, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-10-16

FN filed an 8-K on October 16, 2025, likely to announce its third-quarter financial results.

10-K
10-K
2025-08-19

FN filed its 10-K annual report on August 19, 2025, which includes sections detailing its business operations, risk factors, and management's discussion and analysis of financial condition. Specific financial highlights and risk details were not provided in the available excerpts.

8-K
8-K
2025-08-18
8-K
8-K
2025-05-27
10-Q
10-Q
2025-05-06
8-K
8-K
2025-05-05
8-K
8-K
2025-03-13
10-Q
10-Q
2025-02-04
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
9 analysts
JP Morgan
2026-04-16
down
Overweight Neutral
B. Riley Securities
2026-02-03
Maintains
Neutral Neutral
Barclays
2026-02-03
Maintains
Overweight Overweight
Rosenblatt
2026-02-03
Maintains
Buy Buy
Needham
2026-02-03
reit
Buy Buy
Susquehanna
2026-01-22
Maintains
Positive Positive
Barclays
2026-01-14
up
Equal-Weight Overweight
Susquehanna
2025-12-15
init
Positive
Barclays
2025-11-05
Maintains
Equal-Weight Equal-Weight
JP Morgan
2025-11-04
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning FN from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile